TY - JOUR PY - 2017 DA - 2017// TI - Exploratory double-blind, parallel-group, placebo-controlled study of edaravone (MCI-186) in amyotrophic lateral sclerosis (Japan ALS severity classification: grade 3, requiring assistance for eating, excretion or ambulation) JO - Amyotroph Lateral Scler Frontotemporal Degener VL - 18 UR - https://doi.org/10.1080/21678421.2017.1361441 DO - 10.1080/21678421.2017.1361441 ID - ref1 ER - TY - JOUR AU - Goyal, N. A. AU - Mozaffar, T. PY - 2014 DA - 2014// TI - Experimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugs JO - Expert Opin Investig Drugs VL - 23 UR - https://doi.org/10.1517/13543784.2014.933807 DO - 10.1517/13543784.2014.933807 ID - Goyal2014 ER - TY - STD TI - Katyal N, Govindarajan R. Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement. Front Neurol. 2017;8 Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626834/ [cited 17 Sep 2018]. UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626834/ ID - ref3 ER - TY - STD TI - Paul Mehta M. Prevalence of Amyotrophic Lateral Sclerosis — United States, 2012–2013. MMWR Surveill Summ. 2016;65 Available from: https://www.cdc.gov/mmwr/volumes/65/ss/ss6508a1.htm [cited 17 Sep 2018]. UR - https://www.cdc.gov/mmwr/volumes/65/ss/ss6508a1.htm ID - ref4 ER - TY - JOUR AU - Zach, N. AU - Ennist, D. L. AU - Taylor, A. A. AU - Alon, H. AU - Sherman, A. AU - Kueffner, R. PY - 2015 DA - 2015// TI - Being PRO-ACTive: what can a clinical trial database reveal about ALS? JO - Neurotherapeutics VL - 12 UR - https://doi.org/10.1007/s13311-015-0336-z DO - 10.1007/s13311-015-0336-z ID - Zach2015 ER - TY - STD TI - Hilgers R-D, König F, Molenberghs G, Senn S. Design and analysis of clinical trials for small rare disease populations. J Rare Dis Res Treat. 2016:53–60. ID - ref6 ER - TY - JOUR AU - Atassi, N. AU - Berry, J. AU - Shui, A. AU - Zach, N. AU - Sherman, A. AU - Sinani, E. PY - 2014 DA - 2014// TI - The PRO-ACT database: design, initial analyses, and predictive features JO - Neurology VL - 83 UR - https://doi.org/10.1212/WNL.0000000000000951 DO - 10.1212/WNL.0000000000000951 ID - Atassi2014 ER - TY - STD TI - Statland JM, Moore D, Wang Y, Walsh M, Mozaffar T, Elman L, et al. Rasagiline for amyotrophic lateral sclerosis: a randomized controlled trial. Muscle Nerve. 2018. https://www.ncbi.nlm.nih.gov/pubmed/30192007. UR - https://www.ncbi.nlm.nih.gov/pubmed/30192007 ID - ref8 ER - TY - JOUR AU - Miller, R. G. AU - Moore, D. H. AU - Forshew, D. A. AU - Katz, J. S. AU - Barohn, R. J. AU - Valan, M. PY - 2011 DA - 2011// TI - Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis JO - Neurology VL - 77 UR - https://doi.org/10.1212/WNL.0b013e31822dc7a5 DO - 10.1212/WNL.0b013e31822dc7a5 ID - Miller2011 ER - TY - JOUR AU - Gordon, P. H. AU - Cheung, Y. -. K. AU - Levin, B. AU - Andrews, H. AU - Doorish, C. AU - Macarthur, R. B. PY - 2008 DA - 2008// TI - A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS JO - Amyotroph Lateral Scler VL - 9 UR - https://doi.org/10.1080/17482960802195632 DO - 10.1080/17482960802195632 ID - Gordon2008 ER - TY - JOUR AU - Testa, D. AU - Lovati, R. AU - Ferrarini, M. AU - Salmoiraghi, F. AU - Filippini, G. PY - 2004 DA - 2004// TI - Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period JO - Amyotroph Lateral Scler Other Motor Neuron Disord VL - 5 UR - https://doi.org/10.1080/14660820410021311 DO - 10.1080/14660820410021311 ID - Testa2004 ER - TY - JOUR AU - Pastula, D. M. AU - Coffman, C. J. AU - Allen, K. D. AU - Oddone, E. Z. AU - Kasarskis, E. J. AU - Lindquist, J. H. PY - 2009 DA - 2009// TI - Factors associated with survival in the National Registry of veterans with ALS JO - Amyotroph Lateral Scler VL - 10 UR - https://doi.org/10.3109/17482960802320545 DO - 10.3109/17482960802320545 ID - Pastula2009 ER - TY - JOUR AU - Elamin, M. AU - Bede, P. AU - Montuschi, A. AU - Pender, N. AU - Chio, A. AU - Hardiman, O. PY - 2015 DA - 2015// TI - Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm JO - J Neurol VL - 262 UR - https://doi.org/10.1007/s00415-015-7731-6 DO - 10.1007/s00415-015-7731-6 ID - Elamin2015 ER - TY - JOUR AU - Magnus, T. AU - Beck, M. AU - Giess, R. AU - Puls, I. AU - Naumann, M. AU - Toyka, K. V. PY - 2002 DA - 2002// TI - Disease progression in amyotrophic lateral sclerosis: predictors of survival JO - Muscle Nerve VL - 25 UR - https://doi.org/10.1002/mus.10090 DO - 10.1002/mus.10090 ID - Magnus2002 ER - TY - JOUR AU - Paganoni, S. AU - Deng, J. AU - Jaffa, M. AU - Cudkowicz, M. E. AU - Wills, A. -. M. PY - 2011 DA - 2011// TI - Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis JO - Muscle Nerve VL - 44 UR - https://doi.org/10.1002/mus.22114 DO - 10.1002/mus.22114 ID - Paganoni2011 ER - TY - JOUR AU - Czaplinski, A. AU - Yen, A. A. AU - Appel, S. H. PY - 2006 DA - 2006// TI - Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population JO - J Neurol Neurosurg Psychiatry VL - 77 UR - https://doi.org/10.1136/jnnp.2005.072660 DO - 10.1136/jnnp.2005.072660 ID - Czaplinski2006 ER - TY - JOUR AU - Gordon, P. H. AU - Cheng, B. AU - Salachas, F. AU - Pradat, P. -. F. AU - Bruneteau, G. AU - Corcia, P. PY - 2010 DA - 2010// TI - Progression in ALS is not linear but is curvilinear JO - J Neurol VL - 257 UR - https://doi.org/10.1007/s00415-010-5609-1 DO - 10.1007/s00415-010-5609-1 ID - Gordon2010 ER - TY - JOUR AU - Kimura, F. AU - Fujimura, C. AU - Ishida, S. AU - Nakajima, H. AU - Furutama, D. AU - Uehara, H. PY - 2006 DA - 2006// TI - Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS JO - Neurology VL - 66 UR - https://doi.org/10.1212/01.wnl.0000194316.91908.8a DO - 10.1212/01.wnl.0000194316.91908.8a ID - Kimura2006 ER - TY - JOUR AU - Kollewe, K. AU - Mauss, U. AU - Krampfl, K. AU - Petri, S. AU - Dengler, R. AU - Mohammadi, B. PY - 2008 DA - 2008// TI - ALSFRS-R score and its ratio: a useful predictor for ALS-progression JO - J Neurol Sci VL - 275 UR - https://doi.org/10.1016/j.jns.2008.07.016 DO - 10.1016/j.jns.2008.07.016 ID - Kollewe2008 ER - TY - JOUR AU - Cedarbaum, J. M. AU - Stambler, N. AU - Malta, E. AU - Fuller, C. AU - Hilt, D. AU - Thurmond, B. PY - 1999 DA - 1999// TI - The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS study group (phase III) JO - J Neurol Sci VL - 169 UR - https://doi.org/10.1016/S0022-510X(99)00210-5 DO - 10.1016/S0022-510X(99)00210-5 ID - Cedarbaum1999 ER - TY - JOUR AU - Murphy, S. N. AU - Weber, G. AU - Mendis, M. AU - Gainer, V. AU - Chueh, H. C. AU - Churchill, S. PY - 2010 DA - 2010// TI - Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2) JO - J Am Med Inform Assoc VL - 17 UR - https://doi.org/10.1136/jamia.2009.000893 DO - 10.1136/jamia.2009.000893 ID - Murphy2010 ER - TY - JOUR AU - Waitman, L. R. AU - Warren, J. J. AU - Manos, E. L. AU - Connolly, D. W. PY - 2011 DA - 2011// TI - Expressing observations from electronic medical record flowsheets in an i2b2 based clinical data repository to support research and quality improvement JO - AMIA Annu Symp Proc VL - 2011 ID - Waitman2011 ER - TY - STD TI - Murphy SN, Mendis ME, Berkowitz DA, Kohane I, Chueh HC. Integration of clinical and genetic data in the i2b2 architecture. AMIA Annu Symp Proc. 2006;1040. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1839291/. UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1839291/ ID - ref23 ER - TY - JOUR AU - Armon, C. AU - Graves, M. C. AU - Moses, D. AU - Forté, D. K. AU - Sepulveda, L. AU - Darby, S. M. PY - 2000 DA - 2000// TI - Linear estimates of disease progression predict survival in patients with amyotrophic lateral sclerosis JO - Muscle Nerve VL - 23 UR - https://doi.org/3.0.CO;2-U DO - 3.0.CO;2-U ID - Armon2000 ER - TY - JOUR AU - Karanevich, A. G. AU - Statland, J. M. AU - Gajewski, B. J. AU - He, J. PY - 2018 DA - 2018// TI - Using an onset-anchored Bayesian hierarchical model to improve predictions for amyotrophic lateral sclerosis disease progression JO - BMC Med Res Methodol VL - 18 UR - https://doi.org/10.1186/s12874-018-0479-9 DO - 10.1186/s12874-018-0479-9 ID - Karanevich2018 ER - TY - STD TI - Pinheiro J, Bates D, DebRoy S, Sarkar D, Heisterkamp S, R-core. nlme: Linear and Nonlinear Mixed Effects Models. 2018. Available from: https://CRAN.R-project.org/package=nlme [cited 17 Sep 2018] UR - https://cran.r-project.org/package=nlme ID - ref26 ER - TY - STD TI - Social Security Death Master File -> Home. Available from: https://ladmf.ntis.gov/ [cited 17 Sep 2018] UR - https://ladmf.ntis.gov/ ID - ref27 ER - TY - STD TI - R Core Team. R: a language and environment for statistical computing. [internet]. Vienna, Austria: R Foundation for Statistical Computing; 2017. Available from: https://www.r-project.org/. UR - https://www.r-project.org/ ID - ref28 ER - TY - STD TI - jglaze@madison.com, 608-252-6138 JG. Epic Systems draws on literature greats for its next expansion. madison.com. Available from: https://madison.com/news/local/govt-and-politics/epic-systems-draws-on-literature-greats-for-its-next-expansion/article_4d1cf67c-2abf-5cfd-8ce1-2da60ed84194.html [cited 17 Sep 2018] UR - https://madison.com/news/local/govt-and-politics/epic-systems-draws-on-literature-greats-for-its-next-expansion/article_4d1cf67c-2abf-5cfd-8ce1-2da60ed84194.html ID - ref29 ER - TY - STD TI - i2b2: Informatics for Integrating Biology & the Bedside. Available from: https://www.i2b2.org/work/i2b2_installations.html [cited 17 Sep 2018] UR - https://www.i2b2.org/work/i2b2_installations.html ID - ref30 ER - TY - JOUR AU - Shamshiri, H. AU - Fatehi, F. AU - Davoudi, F. AU - Mir, E. AU - Pourmirza, B. AU - Abolfazli, R. PY - 2015 DA - 2015// TI - Amyotrophic lateral sclerosis progression: Iran-ALS clinical registry, a multicentre study JO - Amyotroph Lateral Scler Frontotemporal Degener VL - 16 UR - https://doi.org/10.3109/21678421.2015.1074698 DO - 10.3109/21678421.2015.1074698 ID - Shamshiri2015 ER - TY - JOUR AU - Watanabe, H. AU - Atsuta, N. AU - Nakamura, R. AU - Hirakawa, A. AU - Watanabe, H. AU - Ito, M. PY - 2015 DA - 2015// TI - Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients JO - Amyotroph Lateral Scler Frontotemporal Degener VL - 16 UR - https://doi.org/10.3109/21678421.2014.990036 DO - 10.3109/21678421.2014.990036 ID - Watanabe2015 ER - TY - JOUR AU - Mandrioli, J. AU - Biguzzi, S. AU - Guidi, C. AU - Sette, E. AU - Terlizzi, E. AU - Ravasio, A. PY - 2015 DA - 2015// TI - Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy JO - Neurol Sci VL - 36 UR - https://doi.org/10.1007/s10072-015-2343-6 DO - 10.1007/s10072-015-2343-6 ID - Mandrioli2015 ER - TY - JOUR AU - Cowie, M. R. AU - Blomster, J. I. AU - Curtis, L. H. AU - Duclaux, S. AU - Ford, I. AU - Fritz, F. PY - 2017 DA - 2017// TI - Electronic health records to facilitate clinical research JO - Clin Res Cardiol VL - 106 UR - https://doi.org/10.1007/s00392-016-1025-6 DO - 10.1007/s00392-016-1025-6 ID - Cowie2017 ER - TY - JOUR AU - Kalin, A. AU - Medina-Paraiso, E. AU - Ishizaki, K. AU - Kim, A. AU - Zhang, Y. AU - Saita, T. PY - 2017 DA - 2017// TI - A safety analysis of edaravone (MCI-186) during the first six cycles (24 weeks) of amyotrophic lateral sclerosis (ALS) therapy from the double-blind period in three randomized, placebo-controlled studies JO - Amyotroph Lateral Scler Frontotemporal Degener VL - 18 UR - https://doi.org/10.1080/21678421.2017.1362440 DO - 10.1080/21678421.2017.1362440 ID - Kalin2017 ER - TY - JOUR AU - Al-Chalabi, A. AU - Andersen, P. M. AU - Chandran, S. AU - Chio, A. AU - Corcia, P. AU - Couratier, P. PY - 2017 DA - 2017// TI - July 2017 ENCALS statement on edaravone JO - Amyotroph Lateral Scler Frontotemporal Degener VL - 18 UR - https://doi.org/10.1080/21678421.2017.1369125 DO - 10.1080/21678421.2017.1369125 ID - Al-Chalabi2017 ER - TY - JOUR AU - Chiò, A. AU - Canosa, A. AU - Gallo, S. AU - Cammarosano, S. AU - Moglia, C. AU - Fuda, G. PY - 2011 DA - 2011// TI - ALS clinical trials: do enrolled patients accurately represent the ALS population? JO - Neurology VL - 77 UR - https://doi.org/10.1212/WNL.0b013e318232ab9b DO - 10.1212/WNL.0b013e318232ab9b ID - Chiò2011 ER - TY - JOUR AU - Miller, R. G. AU - Moore, D. H. AU - Jackson, C. E. PY - 2004 DA - 2004// TI - WALS study group JO - Western ALS Study Group Amyotroph Lateral Scler Other Motor Neuron Disord VL - 5 UR - https://doi.org/10.1080/17434470410019988 DO - 10.1080/17434470410019988 ID - Miller2004 ER - TY - JOUR AU - Hothorn, T. AU - Jung, H. H. PY - 2014 DA - 2014// TI - RandomForest4Life: a random Forest for predicting ALS disease progression JO - Amyotroph Lateral Scler Frontotemporal Degener. VL - 15 UR - https://doi.org/10.3109/21678421.2014.893361 DO - 10.3109/21678421.2014.893361 ID - Hothorn2014 ER -